Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial

Tarih
2006
Yazar
Tzekova, V
Ramlau, R
Jassem, J
Grgic, M
Pinar, S
Szilasi, M
Wiltschke, C
Wagnerova, M
Oskina, N
Soldatenkova, V
Zielinski, C
Wenczl, M
Brodowicz, T
Krzakowski, M
Zwitter, M
Ghilezan, N
Ciuleanuf, T
Cucevic, B
Gyurkovits, K
Ulsperger, E
Üst veri
Tüm öğe kaydını göster
Özet
Purpose: The primary objective of this randomized phase III study was to show significant difference in median time to progression (TTP) in patients with advanced NSCLC treated with single-agent gemcitabine maintenance therapy versus best supportive care following gemcitabine plus cisplatin initial first-line therapy.
Bağlantı
http://hdl.handle.net/20.500.12627/151440
https://doi.org/10.1016/j.lungcan.2006.01.006
Koleksiyonlar